Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124471364 | 12447136 | 4 | F | 20160126 | 20160825 | 20160608 | 20160909 | EXP | FR-CELGENEUS-FRA-2016035281 | CELGENE | 73.57 | YR | F | Y | 0.00000 | 20160909 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124471364 | 12447136 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | U | 21660 | 230 | MG | INJECTION FOR INFUSION | QD | ||||||
| 124471364 | 12447136 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | U | 21660 | INJECTION FOR INFUSION | |||||||||
| 124471364 | 12447136 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | 0 | 1800 | MG | INJECTION FOR INFUSION | QD | ||||||
| 124471364 | 12447136 | 4 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | U | 0 | INJECTION FOR INFUSION | |||||||||
| 124471364 | 12447136 | 5 | SS | FENTANYL. | FENTANYL | 1 | Oral | U | U | 0 | 100 | MG | UNKNOWN | QD | |||||
| 124471364 | 12447136 | 6 | C | DUROGESIC | FENTANYL | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124471364 | 12447136 | 7 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124471364 | 12447136 | 8 | C | DOLIPRANE | ACETAMINOPHEN | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124471364 | 12447136 | 9 | C | HUMALOG | INSULIN LISPRO | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124471364 | 12447136 | 10 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 124471364 | 12447136 | 11 | C | forlax | POLYETHYLENE GLYCOL 4000 | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124471364 | 12447136 | 1 | Pancreatic carcinoma metastatic |
| 124471364 | 12447136 | 3 | Pancreatic carcinoma metastatic |
| 124471364 | 12447136 | 5 | Product used for unknown indication |
| 124471364 | 12447136 | 6 | Product used for unknown indication |
| 124471364 | 12447136 | 7 | Product used for unknown indication |
| 124471364 | 12447136 | 8 | Product used for unknown indication |
| 124471364 | 12447136 | 9 | Product used for unknown indication |
| 124471364 | 12447136 | 10 | Product used for unknown indication |
| 124471364 | 12447136 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124471364 | 12447136 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124471364 | 12447136 | Abdominal pain | |
| 124471364 | 12447136 | Constipation | |
| 124471364 | 12447136 | Nausea | |
| 124471364 | 12447136 | Pancreatic carcinoma metastatic | |
| 124471364 | 12447136 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124471364 | 12447136 | 1 | 20160119 | 20160119 | 0 | |
| 124471364 | 12447136 | 2 | 20160204 | 20160225 | 0 | |
| 124471364 | 12447136 | 3 | 20160119 | 20160119 | 0 | |
| 124471364 | 12447136 | 4 | 20160204 | 20160225 | 0 | |
| 124471364 | 12447136 | 5 | 20160111 | 0 | ||
| 124471364 | 12447136 | 6 | 20160111 | 0 | ||
| 124471364 | 12447136 | 9 | 20160126 | 0 | ||
| 124471364 | 12447136 | 10 | 20160129 | 0 | ||
| 124471364 | 12447136 | 11 | 20160202 | 0 |